---
figid: PMC5352101__oncotarget-08-1814-g003
figtitle: Type I insulin-like growth factor receptor signaling in hematological malignancies
organisms:
- NA
pmcid: PMC5352101
filename: oncotarget-08-1814-g003.jpg
figlink: /pmc/articles/PMC5352101/figure/F3/
number: F3
caption: Binding of IGF-IR to its primary ligand, IGF-I, causes the phosphorylation
  of tyrosine residues present in the intracellular portion of its β subunit. Once
  phosphorylated, Y950 provides a docking site for its substrates IRS-1-4 and SHC
  proteins. Upon substrate binding, downstream signaling is activated through the
  IRS-1/PI3K/AKT/mTOR or SHC/RAS/MAPK pathway, leading to proliferative and anti-apoptotic
  effects, which culminate to oncogenesis and tumor cell survival.
papertitle: Type I insulin-like growth factor receptor signaling in hematological
  malignancies.
reftext: Deeksha Vishwamitra, et al. Oncotarget. 2017 Jan 3;8(1):1814-1844.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9739173
figid_alias: PMC5352101__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5352101__F3
ndex: e60b1904-dec2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5352101__oncotarget-08-1814-g003.html
  '@type': Dataset
  description: Binding of IGF-IR to its primary ligand, IGF-I, causes the phosphorylation
    of tyrosine residues present in the intracellular portion of its β subunit. Once
    phosphorylated, Y950 provides a docking site for its substrates IRS-1-4 and SHC
    proteins. Upon substrate binding, downstream signaling is activated through the
    IRS-1/PI3K/AKT/mTOR or SHC/RAS/MAPK pathway, leading to proliferative and anti-apoptotic
    effects, which culminate to oncogenesis and tumor cell survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - IGF1R
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - PTEN
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - IRS1
  - IRS2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - PDK1
  - PDPK1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - BCL2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - BAD
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - CCL26
  - FOXO1
  - FOXO3
  - EPHB2
  - MAPK1
  - MAPK3
  - RPTOR
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - GSK3B
  - EIF4EBP1
  - RPS6KB1
  - AGRP
  - ARTN
  - Glucose
  - Ser
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
